PremiumCompany AnnouncementsSumitomo Dainippon Pharma Reports Robust Earnings Growth Sumitomo Pharma Revises Financial Forecasts, Projects Positive Turnaround Sumitomo Pharma Reports Significant Foreign Exchange Gains PremiumCompany AnnouncementsSumitomo Pharma Streamlines Workforce with Retirement Program Sumitomo Pharma Reports Significant Forex Losses Sumitomo Pharma upgraded to Neutral from Sell at Citi PremiumCompany AnnouncementsSumitomo Pharma Reports Profit and Revenue Growth Sumitomo Pharma Reports Strong Q1 Revenue Growth Sumitomo Pharma Advances Corporate Governance